| Followers | 1443 |
| Posts | 30453 |
| Boards Moderated | 32 |
| Alias Born | 12/10/2012 |
Tuesday, November 16, 2021 12:23:35 PM
$HEPA: So they didn't get their share raise..........
And are still developing CRV431 with positive outcomes as observed in this latest study.
So tell me, how is that a bad thing ????
Where's the Motivation or Intent in that ?
Would you rather that they have NEGATIVE results issued on the study instead ?
Is that what would be good for the company in compariosn to other NASH stocks out there ?
Tell me another NASH stock thats got more potential with greater upside yield than $HEPA right now ???
GO $HEPA
And are still developing CRV431 with positive outcomes as observed in this latest study.
So tell me, how is that a bad thing ????
Where's the Motivation or Intent in that ?
Would you rather that they have NEGATIVE results issued on the study instead ?
Is that what would be good for the company in compariosn to other NASH stocks out there ?
Tell me another NASH stock thats got more potential with greater upside yield than $HEPA right now ???
GO $HEPA
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM
